Current Research Studies

Atrial Fibrillation

This study will compare an experimental (not yet FDA approved) blood thinner, which reduces the formation of blood clots, against Warfarin (FDA approved) in patients with Atrial Fibrillation.
Click here To Participate

Atrial Fibrillation With Pacemakers

An experimental drug (not yet FDA approved) is being tested to see how well it works and how safe it is in eliminating episodes of atrial fibrillation in patients who have been diagnosed with Atrial Fibrillation and have a pacemaker.
Click here To Participate

Carotid Stenting

Carotid artery stenting is necessary to hold open a carotid artery when a blockage has been diagnosed. This study is utilizing an already FDA approved device and procedure and is merely collecting additional information relative to safety and effectiveness.
Click here To Participate

Cholesterol

The purpose of this study is to compare 2 drugs (already FDA approved) that lower LDL-C (“bad cholesterol) levels in patients who present to the hospital with chest pain.
Click here To Participate

Congestive Heart Failure

The purpose of this study is to test if adding an experimental drug (not yet FDA approved) to your current heart failure treatment(s) is able to safely improve your heart failure.
Click here To Participate

CRT Registry

The purpose of this registry is to evaluate the “usage patterns” of device leads and delivery systems of CRT device implantation at the time of implantation.
Click here To Participate

Drug Eluding Stent

The purpose of this study is to compare a newly designed drug eluding stent, (not yet FDA approved) with an already approved FDA drug eluding stent to show improved performance specific to deliverability while maintaining a similar drug release profile.
Click here To Participate

HeartRate

The purpose of this study is to demonstrate the equivalence of experimental (not yet FDA approved) non-contact electrodes against conventional resistive contact electrodes when monitoring ECGs during the first 4 days following open-heart surgery.
Click here To Participate

MisFit

The purpose of this study is evaluate the safety and effectiveness of an experimental drug (not yet FDA approved) in lowering the chances of having a heart attack, a stroke or dying from a heart attack or stroke in subjects with abdominal obesity at risk for such events.
Click here To Participate

Optimization

This study will compare the capability of an already FDA approved CRT device (cardiac resynchronization therapy device) by either allowing the device to self-optimize its settings or the device will be manually programmed by the implanting doctor to optimize the settings.
Click here To Participate

Platelet Block

The purpose of this study is to test the safety and effectiveness of an experimental drug (not yet FDA approved) that blocks platelets (platelets “stick” together and can form blood clots) when used together with standard medications for atherosclerosis.
Click here To Participate

Valve Replacement

The purpose of this study is to define the lowest level of required antithrombotic (anti-blood clotting) therapy for prostheses in patients who have been diagnosed with heart valve disease and require replacement of their natural aortic or mitral valve.
Click here To Participate